Yao, R., Hu, X., Zhou, S., Zhang, Q., Huang, H., Sun, N., . . . Lin, Y. (2019). Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China. Medicine (Baltimore).
Citação norma ChicagoYao, Rongxin, Xudong Hu, Shuping Zhou, Qianying Zhang, He Huang, Ni Sun, Wenjian Guo, Kang Yu, and Ying Lin. "Once-weekly Bortezomib Had Similar Effectiveness and Lower Thrombocytopenia Occurrence Compared With Twice-weekly Bortezomib Regimen in Treating Patients With Newly Diagnosed Multiple Myeloma in China." Medicine (Baltimore) 2019.
MLA citiranjeYao, Rongxin, et al. "Once-weekly Bortezomib Had Similar Effectiveness and Lower Thrombocytopenia Occurrence Compared With Twice-weekly Bortezomib Regimen in Treating Patients With Newly Diagnosed Multiple Myeloma in China." Medicine (Baltimore) 2019.